Trending...
- Peak 10 Marketing Expands Capabilities and Opens Doors to New Clients - 105
- How LIB's Temperature & Humidity Chamber & Walk-in Chamber Warranty Delivered Real Uptime
- Aktion Associates Acquires Deltek Practice from AMR Group
CLEVELAND, July 8, 2021 /PRNewswire/ -- The Harrington Discovery Institute at University Hospitals in Cleveland, Ohio, today announced the 2021 class of Harrington Scholar-Innovators. The scholar awards will support a diverse set of drug discovery projects including new treatments for multiple cancers, cardiovascular disease, Graft vs. Host disease, liver injury/fibrosis (NASH), Parkinson's disease, and the emerging field of longevity and aging.
The Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact. In addition to grant funding, Harrington provides guidance and oversight in all aspects of drug development through its Therapeutics Development Center, while taking no rights to intellectual property.
More on Ohio Pen
"We are incredibly inspired by the brilliant science demonstrated by these eight physician-scientists," said Jonathan S. Stamler, MD, President of the Harrington Discovery Institute at University Hospitals and Robert S. and Sylvia K. Reitman Family Foundation Distinguished Professor of Cardiovascular Innovation and Professor of Medicine and of Biochemistry at Case Western Reserve University. "In surrounding each Scholar with an experienced pharma and business development team with a track record of bringing new drugs to market, we are maximizing the therapeutic potential of great science."
The selected Scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute, as well as facilitated access to our mission-aligned commercial partners Advent-Harrington Impact Fund and BioMotiv, and to our charitable partner Morgan Stanley GIFT Cures.
More on Ohio Pen
The 2021 Harrington Scholar-Innovator Award recipients, their organizations and fields of research are:
Jennifer Chen, MD – University of California, San Francisco
Reversing Liver Fibrosis
John Chorba, MD – University of California, San Francisco
A Novel Treatment for Atherosclerosis
Joseph Contessa, MD, PhD – Yale University
A New Target and Drug for Lung Cancer
Toren Finkel, MD, PhD – University of Pittsburgh
Anti-aging Agents
Maria Grazia Roncarolo, MD – Stanford University
New Cell Therapy for Transplantation
Aaron Schimmer, MD – University of Toronto
A Treatment for Multiple Cancers and Neurological Diseases
Jill Smith, MD – Georgetown University
A New Treatment for Pancreatic Cancer
Xinnan Wang, MD, PhD – Stanford University
Targeting and Treating Parkinson's Disease
SOURCE Harrington Discovery Institute
The Harrington Discovery Institute—part of The Harrington Project for Discovery & Development—was established in 2012 to accelerate the development of new treatments to address major unmet needs in medicine and society. Harrington Scholar-Innovators are accomplished physician-scientists whose research demonstrates innovation, creativity and potential for clinical impact. In addition to grant funding, Harrington provides guidance and oversight in all aspects of drug development through its Therapeutics Development Center, while taking no rights to intellectual property.
More on Ohio Pen
- Youth Take the Lead: Kopp Foundation for Diabetes Hosts "By Youth, For Youth, With T1D" Gala on October 8 at Blue Bell Country Club
- Green Office Partner Named #1 Best Place to Work in Chicago by Crain's for 2025
- CCHR, a Mental Health Watchdog Organization, Hosts Weekly Events Educating Citizens on Important Mental Health Issues
- "Leading From Day One: The Essential Guide for New Supervisors" Draws from 25+ Years of International Management Experience
- Actor, Musician and Poker Player Nicholas Rascona to Take to ACR Poker Tables to Break Guinness World Record for Longest Marathon Playing Online Poker
"We are incredibly inspired by the brilliant science demonstrated by these eight physician-scientists," said Jonathan S. Stamler, MD, President of the Harrington Discovery Institute at University Hospitals and Robert S. and Sylvia K. Reitman Family Foundation Distinguished Professor of Cardiovascular Innovation and Professor of Medicine and of Biochemistry at Case Western Reserve University. "In surrounding each Scholar with an experienced pharma and business development team with a track record of bringing new drugs to market, we are maximizing the therapeutic potential of great science."
The selected Scholars have access to several rounds of capital (up to a total of $700,000) through their affiliation with the Harrington Discovery Institute, as well as facilitated access to our mission-aligned commercial partners Advent-Harrington Impact Fund and BioMotiv, and to our charitable partner Morgan Stanley GIFT Cures.
More on Ohio Pen
- New Slotozilla Project Explores What Happens When the World Goes Silent
- The Two Faces of Charles D. Braun: How the Novel, Posthumously Yours, Came to Life
- "The Omniscient Buyer" Launches, Offering a Wake-Up Call for the AI Era of Sales and Marketing
- Counseling Center of New Smyrna Beach Expands Affordable Mental Health Services for Volusia County
- Rise & Rally:Her Legacy Invitational
The 2021 Harrington Scholar-Innovator Award recipients, their organizations and fields of research are:
Jennifer Chen, MD – University of California, San Francisco
Reversing Liver Fibrosis
John Chorba, MD – University of California, San Francisco
A Novel Treatment for Atherosclerosis
Joseph Contessa, MD, PhD – Yale University
A New Target and Drug for Lung Cancer
Toren Finkel, MD, PhD – University of Pittsburgh
Anti-aging Agents
Maria Grazia Roncarolo, MD – Stanford University
New Cell Therapy for Transplantation
Aaron Schimmer, MD – University of Toronto
A Treatment for Multiple Cancers and Neurological Diseases
Jill Smith, MD – Georgetown University
A New Treatment for Pancreatic Cancer
Xinnan Wang, MD, PhD – Stanford University
Targeting and Treating Parkinson's Disease
SOURCE Harrington Discovery Institute
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Crimson Cup Congratulates 15 Independent Coffee Shops in 8 States Marking September Anniversaries
- CCHR: For Prevention, Families Deserve Truth From NIH Study on Psychiatric Drugs
- Sheets.Market Brings Professional Financial Model Templates to Entrepreneurs and Startups
- Webinar Announcement: Investing in the European Defense Sector—How the New Era of Uncertainty Is Redefining Investment Strategies
- AEVIGRA (AEIA) Analysis Reveals $350 Billion Counterfeit Market Driving Luxury Sector Toward Blockchain Authentication
- Galaxy Service Partners Announces Partnership with Thomas Door
- Her Magic Mushroom Memoir Launches as a Binge-Worthy Novel-to-Podcast Experience
- Century Fasteners de Mexico Hires Saúl Pedraza Gómez as Regional Sales Manager in Mexico
- Georgia Misses the Mark Again on Sports Betting, While Offshore Sites Cash In
- $40 Price Target for $NRXP in H. C. Wainright Analyst Report on Leader in $3 Billion Suicidal Depression Market with Superior NRX 100 Drug Therapy
- VidCliq Launches Faceless2Famous Project with AI Artist Truf as Podcast Host
- Nashville International Chopin Piano Competition Partners with Crimson Global Academy to Support Excellence in Education
- AHRFD Releases Market Analysis: Cryptocurrency Market's Institutional Transformation Accelerating
- Wellness Coach Zakiyyah Broadnax Joins the Dear Black Woman Anthology
- Summit Named to Columbus Business First's Fast 50 for the Fourth Time
- Ubleu Crypto Group Analyzes European Digital Asset Market Opportunities Amid Regulatory Evolution
- NIUFO Examines European MiCA Regulation's Impact on Digital Asset Trading Markets
- Wzzph Analyzes Crypto Market Maturation as Institutional Capital Drives $50B ETF Inflows
- GXCYPX Analyzes South America's Emerging Digital Asset Market Dynamics
- Keyanb Crypto Exchange Positions for Latin America's $600 Billion Remittance Opportunity Amid Global Regulatory Shifts